Authors/Disclosures
|
Francisco Cardoso, MD, FÂ鶹´«Ã½Ó³»
(UFMG)
|
Dr. Cardoso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventus. Dr. Cardoso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Knight. Dr. Cardoso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for M8. Dr. Cardoso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Cardoso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa. Dr. Cardoso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Cardoso has a non-compensated relationship as a Chair of ICOC with MDS that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
John Papatriantafyllou, MD
(John Papatriantafyllou)
|
Dr. Papatriantafyllou has nothing to disclose. |
|
Lindsay N. Alfano, PT
(Nationwide Children'S Hospital)
|
Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care. |